GlassScriptPhysician profile
Andrew Rodgers
NPI 1063613420
$3,533.04
in general payments reported to CMS, 2019-2025
12 companies · $487 in 2025
The $487 reported for 2025 was more than what 79% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,540 · 2020: $80.08 · 2021: $118 · 2022: $457 · 2023: $677 · 2024: $174 · 2025: $487.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,337.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Canon Medical Systems USA, INC. | $1,540.32 | 2019 | |
| Bard Peripheral Vascular, INC. | $441.37 | 2023-2025 | Elevation, Trek |
| Medtronic, INC. | $318.29 | 2021-2025 | Solitaire X, Venaseal |
| Penumbra, INC. | $282.44 | 2022-2025 | Ruby Coil |
| Stryker Corporation | $270.32 | 2021-2025 | Trevo |
| Siemens Medical Solutions USA, INC. | $186.78 | 2023 | Magnetom Vida |
| Boston Scientific Corporation | $132.16 | 2025 | Embold Fibered |
| Microvention, INC. | $98.00 | 2022 | |
| Merit Medical Systems INC | $80.08 | 2020 | |
| Xact Robotics LTD | $68.74 | 2021-2022 | |
| Becton, Dickinson and Company | $63.58 | 2025 | Pleurx |
| Dermavant Sciences, INC. | $50.96 | 2023-2024 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Rodgers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.